Stocks of Zimmer Biomet - Current price, Where to buy? Dividends
| Detail | Data |
|---|---|
| Stocks: | Zimmer Biomet |
| ompany Name: | Zimmer Biomet Holdings, Inc. |
| Ticker: | ZBH |
| Exchange: | NYSE |
| Outstanding stocks: | 205,460,992 |
| 24-hour Volume: | 755,452 |
| Industry: | Medical Devices |
| Sector: | Healthcare |
| Number of Employees: | 18000 |
| Country: | United States |
| City: | Warsaw |
| Address: | 345 East Main Street |
| P/E Ratio: | Forward P/E | EPS: | Forward EPS | Book value per share | Market capitalization |
|---|---|---|---|---|---|
| 26.09 | 14.67 | 4.88 USD | 8.68 USD | 60.70 USD | 24,338,909,184.00 USD |
| P/E Ratio: | 26.09 |
|---|---|
| Forward P/E: | 14.67 |
| EPS: | 4.88 USD |
| Forward EPS: | 8.68 |
| Book value per share: | 60.70 USD |
| Market capitalization: | 24,338,909,184.00 USD |
Zimmer Biomet
Fundamental Indicators
| Indicator | Data |
|---|---|
| Total Revenue: | 7,394,200,064.00 USD |
| Net Income: | 1,024,000,000.00 USD |
| Price-to-Book (P/B) Ratio: | 2.10 |
| PEG Ratio: | 2.28 |
Note: The data is approximate, subject to change over time, and may not be current; however, we strive for the highest possible accuracy.
Analysts' predictions
| Analysts | Recommendation |
|---|---|
| Issued Recommendation: | According to our data, the recommendation issued for Zimmer Biomet stocks is: hold |
| Number of Analysts: | 23 |
| Highest Target Price: | 160 USD |
| Lowest Target Price: | 109 USD |
| Average Target Price: | 136 USD |
Note: The data is approximate. Recommendations and price forecasts for Zimmer Biomet stocks based on analysts' ratings may change over time. Some recommendations may already be outdated and may not be accurate. We strongly advise against buying and selling stocks based on analysts' recommendations!
Dividend
| Dividends | Value |
|---|---|
| Dividend Amount | Company Zimmer Biomet pays a dividend of 0.96 USD per share. |
| Annual Yield %: | 0.75 % |
| Ex-dividend Date: | 2024-03-27 |
| Average % Yield for 5 Years: | 0.74 % |
| Payout Ratio: | 19.67 % |
| Value of Last Dividend Paid: | 0.24 USD |
| Date of Last Dividend: | 2024-03-27 |
The dividend is displayed for the entire calendar year, however, it is usually paid out quarterly in parts. Data may change!
Where to Buy Zimmer Biomet Stocks?
If you're interested in investing in Zimmer Biomet stocks and believe in their future growth, you can purchase them through stock brokers like XTB or eToro. To make buying easier, we've prepared a table with offers from these brokers, including quick purchase of Zimmer Biomet stocks through mobile apps with client support. In this table, you can compare brokers offering real Zimmer Biomet stocks. Brokers providing the option to buy real stocks (not CFDs) are identified by "Real Stocks" in the comparison table column.
| Broker | Platforms | Regulation | Min. Deposit | Deposits / Withdrawals | CopyTrader | Real Stocks | Website Link |
|---|---|---|---|---|---|---|---|
 |
Proprietary platform, social network + CopyTrader™ | 100 USD | Bank transfer, credit cards, Skrill, PayPal, Neteller |
 Go to eToro
|
|||
 |
xStation, mobile version | 10 USD | Credit cards, Skrill, bank transfer |
 Go to XTB
|
|
|
| xStation, mobile version | Proprietary platform, social network + CopyTrader™ |
|
Go to XTB
|
Go to eToro
|
More Information about Zimmer Biomet (ZBH)
Zimmer Biomet consistently proves itself as a leader in its industry. Total revenues for the last 12 months exceed 7,394,200,064.00 USD, demonstrating its strong market position and ability to generate high revenues. With EBITDA reaching 2,448,900,096.00 USD, Zimmer Biomet maintains a high level of efficiency and profitability. This highlights its ability to manage operational costs effectively. Debt-to-equity ratio of 0.50 suggests that Zimmer Biomet has a healthy financial structure and effectively manages its debts. This is key to stable growth. Gross margin of 71.82% shows that Zimmer Biomet efficiently manages costs and maintains a high share of revenues. This is a sign of a strong market position. Lower profit margin of 13.85% suggests opportunities for Zimmer Biomet to increase efficiency and reduce costs.
| Indicator | Value |
|---|---|
| Revenue, Debt, and Cash Flow | |
| Company Revenue: | 7,394,200,064.00 USD |
| EBITDA: | 2,448,900,096.00 USD - Positive EBITDA indicates profitable operations before interest, taxes, depreciation, and amortization. |
| Earnings Per Share: | 4.88 USD |
| Book Value Per Share: | 60.70 USD |
| Total Cash: | 415,800,000.00 USD |
| Total Cash per Share: | 2.03 USD |
| Total Debt: | 6,208,000,000.00 USD |
| Debt to Equity Ratio: | 0.50 |
| Quick Ratio: | 0.65 |
| Current Ratio: | 1.61 |
| Free Cash Flow: | 1,136,999,936.00 USD |
| Operating Cash Flow: | 1,581,600,000.00 USD |
| Company Margins | |
| Gross Margins: | 71.82 % |
| EBITDA Margins: | 33.12 % |
| Operating Margins: | 23.70 % |
| Profit Margins: | 13.85 % |
| Performance | |
| Return on Assets: | 4.4 % |
| Return on Equity: | 8.4 % |
| Earnings Growth (1 year): | / |
| Revenue Growth (1 year): | 6.3 % |
| Year-over-Year Quarterly Earnings Growth: | / |
| Valuation | |
| Market Capitalization: | 24,338,909,184.00 USD |
| Enterprise Value: | 31,913,248,768.00 USD |
| EV/Revenue: | 4.316 |
| EV/EBITDA: | 13.032 |
| Number of Shares and Short Shares | |
| Float Shares: | 204,563,109 shares |
| Shares Outstanding: | 205,460,992 shares |
| Held Percent Insiders: | 0.00 % |
| Held Percent Institutions: | 90.99 % |
| Shares Short: | 4,589,588 |
| Shares Short Prior Month: | 4,173,640 |
| Date Short Interest: | 2024-03-15 |
| Shares Percent Shares Out: | 2.23 % |
| Short Ratio: | 3.30 |
| Beta: | 1.02 |
| Short Percent of Float: | 2.53 % |
| Předpokládaný počet akcií: | 205,460,992 |
Frequently Asked Questions (FAQ)
The company Zimmer Biomet pays a dividend of 0.96 USD per share. At this rate, the annual yield is 0.75 %.
Zimmer Biomet shares are traded on the stock exchange NYSE under the ticker symbol: ZBH. You can buy or trade them with a variety of stock brokers offering real stock trading services.
According to our data, there is a hold recommendation issued for Zimmer Biomet shares by a total of 23 analysts. The average target price prediction is 136 USD per share.
The total number of Zimmer Biomet shares on the exchange is 205,460,992.00, which, at the current market capitalization, values the company at 24,338,909,184.00 USD.
